Skip to Main Content

Paper Details

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
Neurooncol Adv
4
2023
/B, BM, BMs, CDKN2A, CNS, brain, brain metastases, brain metastasis, cancer, co, coding regions, oncogenes, patient, patients
Author NameAffiliation
Edward F ChangUniversity of California san francisco
Michael W McDermottMiami Neuroscience Institute
Michael W McDermottMiami Neuroscience Institute
Mitchel S BergerUniversity of California san francisco
Mitchel S BergerUniversity of California san francisco
Mariza DarasUniversity of California san francisco
Manish K AghiUniversity of California san francisco
  • 1 - 7

Datasets

Release 1.2